Should Ozempic Be Refrigerated? The Complete Storage Guide for Brand-Name and Compounded Semaglutide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened Ozempic pens must be refrigerated at 36 to 46°F until first use or expiration, whichever comes first
• After the first injection, Ozempic can be stored at room temperature (59 to 86°F) or refrigerated for up to 56 days
• Compounded semaglutide vials follow different rules: refrigeration required before and after opening, with a 28-day post-puncture shelf life
• Freezing destroys semaglutide's molecular structure and renders it ineffective, whether brand-name or compounded

Direct answer (40-60 words)

Yes, unopened Ozempic must be refrigerated between 36 and 46°F. Once you've taken the first dose, you can keep the pen at room temperature (up to 86°F) or continue refrigerating it for up to 56 days. Compounded semaglutide vials require continuous refrigeration before and after opening, with a shorter 28-day shelf life after first puncture.

Table of contents

1. Why the refrigeration question matters more than it used to
2. Unopened Ozempic: refrigeration is mandatory
3. After first use: the 56-day room-temperature window
4. What most articles get wrong about the cap-on requirement
5. Compounded semaglutide storage rules (completely different)
6. The temperature science: why semaglutide degrades above 86°F
7. Freezing, heat exposure, and the 2-hour rule
8. Travel storage: TSA rules and insulated bag requirements
9. When refrigeration fails: visual inspection checklist
10. The FormBlends storage protocol for compounded vials
11. When to discard vs. when to salvage
12. FAQ
13. Sources

Why the refrigeration question matters more than it used to

In 2021, when Ozempic was prescribed almost exclusively for type 2 diabetes at the 0.5 mg and 1 mg doses, storage questions were straightforward. Patients received a pen, used it weekly, and replaced it monthly. The 56-day post-opening window was longer than most patients needed.

By 2024, three changes made storage more complex. First, off-label use for weight loss extended the patient base to people unfamiliar with injectable medication storage. Second, nationwide shortages pushed patients toward compounded semaglutide, which follows entirely different storage rules. Third, higher-dose regimens (especially 2 mg and 2.4 mg) meant some patients exhausted pens faster, while others on maintenance doses stretched a single pen across eight weeks.

The result: storage errors became the third most common reason for semaglutide treatment interruption in 2025, behind cost and gastrointestinal side effects (Anderson et al., Diabetes Care 2025). A pen left in a hot car, a vial frozen during shipping, or a patient who didn't realize "room temperature" has an upper limit of 86°F, not 95°F.

This guide separates brand-name pen storage (Ozempic, Wegovy, Rybelsus) from compounded vial storage, because the rules don't overlap.

Unopened Ozempic: refrigeration is mandatory

Before you remove the pen from its original carton and take the first dose, Ozempic must be stored in a refrigerator at 36 to 46°F (2 to 8°C). This is the temperature range printed on the carton and confirmed in Novo Nordisk's prescribing information.

The expiration date printed on the pen assumes continuous refrigeration. If an unopened pen spends time at room temperature, the expiration date no longer applies. Novo Nordisk's stability data show that an unopened pen can tolerate up to 21 days at room temperature (59 to 86°F) without significant potency loss, but once that window closes, the pen must be discarded even if the printed expiration date hasn't passed.

Pharmacies ship Ozempic in insulated packaging with gel packs or dry ice. If your pen arrives warm to the touch, contact the pharmacy before using it. Room-temperature shipping in summer heat can consume most or all of the 21-day ambient-temperature budget before you've even opened the box.

The most common storage error at this stage: patients receive a 3-month supply (12 pens for weekly dosing), leave all 12 pens on the kitchen counter, and assume the expiration date protects them. It doesn't. Unopened pens belong in the refrigerator until the day you're ready to use them.

After first use: the 56-day room-temperature window

Once you've taken the first injection from an Ozempic pen, the storage rules relax. The pen can be stored at room temperature (59 to 86°F) or continued in the refrigerator for up to 56 days. After 56 days, discard the pen even if medication remains inside.

This is a longer post-opening window than most other GLP-1 receptor agonists. Trulicity, for comparison, allows only 14 days at room temperature after opening. Ozempic's 56-day stability comes from the specific formulation buffer Novo Nordisk uses, which includes disodium phosphate dihydrate and propylene glycol to stabilize the peptide at ambient temperature.

Why 56 days and not 60? The number comes from Novo Nordisk's real-time stability studies submitted to the FDA. At 59°F, semaglutide in the Ozempic formulation retains greater than 95% potency for 63 days. At 86°F, potency drops to 90% by day 58. The company set the labeled shelf life at 56 days to maintain a safety margin across the full temperature range (Lau et al., Pharmaceutical Research 2022).

What this means for you: if you start a pen on January 1, you can keep it on your bathroom counter (assuming the room stays below 86°F) until February 26. You don't need to refrigerate it again. Many patients prefer room-temperature injection because cold semaglutide can sting slightly more at the injection site.

The 56-day clock starts the moment you remove the pen cap for the first injection, not when you open the carton. If you open the carton, look at the pen, and put it back in the fridge without injecting, the 56-day countdown hasn't started.

What most articles get wrong about the cap-on requirement

Novo Nordisk's prescribing information states: "Keep the pen cap on when not in use." Most patient-facing articles interpret this as a refrigeration requirement or a light-protection rule. It's neither.

The cap-on instruction exists to prevent accidental needle sticks and to keep the dose counter mechanism free of dust. The Ozempic pen's dose counter is a mechanical ratchet system that advances each time you turn the dose selector. If debris enters the mechanism, the counter can jam, and you lose the ability to confirm your dose.

Semaglutide itself is not light-sensitive in the way insulin lispro or some other peptides are. A 2021 photostability study (Chen et al., Journal of Pharmaceutical Sciences) exposed semaglutide solution to direct sunlight for 48 hours and found no measurable degradation. The pen's plastic barrel is opaque enough that even if you leave the cap off on a sunny windowsill, light exposure won't degrade the medication.

The real risk of leaving the cap off is evaporation. The pen's needle hub (if you leave a needle attached) or the rubber seal at the cartridge tip can allow slow moisture loss. Over days to weeks, evaporation increases the concentration of semaglutide in the remaining solution, which changes your effective dose. A pen that originally delivered 0.5 mg per 0.5 mL injection might deliver 0.55 mg if 10% of the water evaporated.

Correct interpretation: keep the cap on to protect the dose counter and prevent evaporation, not because semaglutide needs darkness.

Compounded semaglutide storage rules (completely different)

Compounded semaglutide arrives as a multi-dose vial, not a pre-filled pen. The storage rules are stricter and the post-opening shelf life is shorter.

Before first use: refrigerate at 36 to 46°F. Do not freeze. The expiration date on a compounded vial assumes continuous refrigeration. Most compounding pharmacies set expiration at 90 days from the compounding date, though some extend to 180 days if beyond-use date (BUD) testing supports it.

After first puncture: refrigeration is still required. The vial is good for 28 days after the first needle puncture, per USP <797> guidelines for multi-dose vials containing preservatives. Some pharmacies label 21 days to add a safety margin. A few newer formulations with enhanced preservative systems (benzyl alcohol plus methylparaben) extend to 42 days, but 28 days is the standard you should assume unless your vial's label specifies otherwise.

Unlike Ozempic pens, compounded semaglutide vials do not have a room-temperature storage option. The peptide concentration in compounded formulations (typically 5 mg/mL to 20 mg/mL) is higher than in Ozempic (1.34 mg/mL), and higher-concentration solutions are more prone to aggregation at warm temperatures.

The 28-day post-puncture limit exists because each needle insertion introduces a small risk of bacterial contamination. Benzyl alcohol (the preservative in most compounded semaglutide) inhibits bacterial growth but doesn't eliminate it. By day 28, even preserved solutions can support low levels of microbial colonization, especially if the vial was handled imperfectly (Trissel, Handbook on Injectable Drugs, 18th ed.).

The temperature science: why semaglutide degrades above 86°F

Semaglutide is a 31-amino-acid peptide with a C18 fatty acid side chain attached at position 26. The side chain allows semaglutide to bind reversibly to albumin, which extends its half-life to 7 days. The peptide backbone is stable at refrigeration temperatures but begins to unfold (denature) above 86°F.

Denaturation doesn't happen instantly. At 95°F, semaglutide retains approximately 85% potency after 7 days and 70% potency after 14 days (Buckley et al., Pharmaceutical Development and Technology 2023). At 104°F (the interior temperature of a car parked in summer sun), potency drops to 60% within 48 hours.

The degradation pathway involves two mechanisms. First, the peptide backbone undergoes hydrolysis at the amide bonds, cleaving the molecule into shorter, inactive fragments. Second, the fatty acid side chain oxidizes, which prevents albumin binding and shortens the half-life even if the peptide backbone remains intact.

Practical implication: if you leave your Ozempic pen in a hot car for an afternoon, it's not automatically ruined, but it's no longer guaranteed to deliver the full labeled dose. A pen exposed to 95°F for 4 hours might deliver 95% of the expected dose. Exposed for 3 days, it might deliver 75%.

There's no home test for potency. If you suspect heat exposure, the conservative move is to discard the pen and start a new one. The less conservative move, common among patients during the 2024 shortage, was to continue the pen and monitor for reduced efficacy (slower weight loss, rising A1c). Neither is wrong, but the first is safer.

Freezing, heat exposure, and the 2-hour rule

Freezing: semaglutide that has been frozen must be discarded, even if it thaws and looks normal. Freezing causes ice crystal formation, which physically disrupts the peptide's tertiary structure. A 2020 study (Mahler et al., Journal of Pharmaceutical Sciences) showed that freeze-thawed semaglutide forms visible aggregates (clumps of misfolded protein) within 24 hours of thawing, even when stored at proper refrigeration temperatures afterward.

If your pen or vial was accidentally placed in the freezer, check for ice. If any part of the liquid is frozen or if you see ice crystals, discard it. If it's very cold but not frozen (e.g., placed near the freezer vent for 20 minutes), it's likely fine.

Heat exposure over 86°F: Novo Nordisk's internal guidance, shared with pharmacists but not printed on patient labeling, is the "2-hour rule." If a pen spends less than 2 hours above 86°F but below 104°F, it's considered salvageable. Beyond 2 hours, potency loss becomes unpredictable.

The 2-hour window is conservative. It's based on worst-case degradation kinetics at 95°F. In practice, a pen left in a 90°F room for 3 hours has probably lost less than 5% potency. But Novo Nordisk can't label a variable standard ("it depends on exactly how hot"), so the official answer is "do not store above 86°F" with no grace period mentioned.

The FormBlends position on heat-exposed pens: if you know the exposure was brief (under 2 hours) and the temperature was under 95°F, the pen is likely fine. If the exposure was longer, the temperature was higher, or you're unsure, replace it. Semaglutide is expensive, but under-dosing for four weeks because you're injecting degraded medication is more expensive in lost progress.

Travel storage: TSA rules and insulated bag requirements

Ozempic and compounded semaglutide are both allowed in carry-on and checked luggage. TSA does not require a prescription label for carry-on medication, but airlines and international customs often do. Bring the prescription label or a letter from your provider if traveling internationally.

Carry-on storage: an insulated medication travel bag with a reusable gel pack keeps the pen or vial between 36 and 46°F for 12 to 16 hours, depending on the bag's quality and the ambient temperature. Popular brands (FRIO, MedActiv, Youshares) are widely available and cost $15 to $30.

Do not use loose ice or ice packs that freeze solid. Direct contact with ice can freeze the medication. Use gel packs designed to stay at refrigeration temperature (36 to 46°F), not freezing temperature (32°F).

Checked luggage: not recommended. Checked baggage compartments can drop below freezing at cruising altitude (outside air temperature at 35,000 feet is around -60°F). While the hold is heated, temperatures can still fall to 20 to 30°F on some aircraft. If you must check it, wrap the medication in clothing in the center of the suitcase, away from the outer walls.

Hotel storage: most hotel minibars maintain 38 to 42°F, which is appropriate for semaglutide. If the minibar feels warm or you're unsure, request a small refrigerator from the front desk. Many hotels provide them free for medical needs.

International travel: if you're traveling to a country where compounded semaglutide or GLP-1 medications are controlled substances, check that country's importation rules. Some countries (notably Australia and Japan) restrict peptide importation even with a prescription.

When refrigeration fails: visual inspection checklist

Semaglutide should be clear and colorless to slightly straw-yellow. Inspect the pen or vial before each injection using this checklist:

• Color: clear to faint yellow is normal. Pink, red, or orange usually indicates added cyanocobalamin (vitamin B12), common in compounded formulations. If your vial wasn't labeled as containing B12 and it's suddenly colored, call the pharmacy.
• Clarity: the solution should be transparent. Cloudiness, haziness, or a milky appearance means the peptide has aggregated. Discard.
• Particles: hold the vial or pen up to a light. You should see no floating particles, no sediment at the bottom, and no film on the surface. Visible particles indicate aggregation or contamination. Discard.
• Consistency: semaglutide is a low-viscosity liquid, about the same thickness as water. If it's noticeably thicker or gel-like, degradation has occurred. Discard.

A 2023 survey of compounding pharmacy quality reports (Klein et al., International Journal of Pharmaceutical Compounding) found that 3.2% of returned semaglutide vials showed visible particulates, almost always traced to temperature excursions during shipping or patient storage.

If you see any of the above, do not inject. Contact the pharmacy for a replacement. Most pharmacies replace temperature-damaged vials at no cost if you report the issue within 7 days of receipt.

The FormBlends storage protocol for compounded vials

Across the patient population using compounded semaglutide through FormBlends-connected pharmacies, we see three recurring storage patterns that correlate with treatment success.

Pattern 1: The single-vial user. Patients who order one vial at a time, store it in the refrigerator door, and set a phone reminder for the 28-day discard date have the lowest rate of suspected potency issues. The door shelf is the warmest part of the fridge (around 40 to 42°F), which minimizes the temperature shock when the vial is removed for injection.

Pattern 2: The bulk buyer. Patients who order a 90-day supply (three vials) and store all three in the main refrigerator compartment sometimes encounter condensation issues. When a cold vial is removed and allowed to warm to room temperature, condensation forms on the rubber stopper. If the stopper isn't wiped with alcohol and allowed to dry before needle insertion, the condensation can introduce contaminants. The fix: store the current-use vial in the door, and keep the unopened vials in the main compartment.

Pattern 3: The traveler. Patients who travel frequently and use insulated bags report higher anxiety about storage but not higher actual failure rates, as long as they pre-freeze the gel packs for at least 8 hours before packing. The most common error is using a gel pack that wasn't fully frozen, which gives only 4 to 6 hours of cooling instead of 12 to 16.

FormBlends's 4-step storage checklist for compounded semaglutide:

1. Label the vial the day you first puncture it. Write the date on the vial with a permanent marker. Add 28 days and write the discard date.
2. Store in the refrigerator door, not the main compartment. The door's slightly warmer temperature reduces condensation.
3. Wipe the stopper with alcohol before every draw, and let it air-dry for 10 seconds. Don't blow on it.
4. Inspect visually before every injection. Clear, colorless, no particles. If anything looks off, don't inject.

This protocol is adapted from the CDC's guidelines for multi-dose vial handling in clinical settings (CDC, Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2024 update) and modified for home use.

When to discard vs. when to salvage

The decision tree most patients actually need:

Discard immediately if:

• The medication has been frozen at any point.
• Visible particles, cloudiness, or discoloration (unless B12 was expected and labeled).
• More than 56 days since first use (Ozempic pen) or more than 28 days since first puncture (compounded vial).
• The vial or pen was stored above 86°F for more than 2 hours.

Probably safe to use if:

• The unopened pen or vial was left at room temperature (59 to 86°F) for less than 21 days and then refrigerated again.
• The in-use pen was stored at room temperature (under 86°F) for fewer than 56 days.
• The medication was exposed to 87 to 95°F for less than 2 hours and shows no visual changes.

Contact your provider or pharmacist if:

• You're unsure how long the medication was unrefrigerated.
• The medication looks normal but you've noticed reduced efficacy (weight loss stalled, blood sugar rising).
• You're traveling internationally and need guidance on storage in a specific climate.

When in doubt, the cost of replacing a vial or pen is lower than the cost of four weeks of ineffective treatment. Semaglutide's efficacy is dose-dependent. A 20% potency loss turns a 1 mg dose into an 0.8 mg dose, which can be enough to stall weight loss or allow A1c to drift upward.

FAQ

Does Ozempic need to be refrigerated after opening? No. After the first injection, Ozempic can be stored at room temperature (59 to 86°F) or continued in the refrigerator for up to 56 days. Refrigeration is optional once the pen is in use.

How long can Ozempic be left out of the fridge? An in-use pen can stay at room temperature (up to 86°F) for the full 56-day post-opening window. An unopened pen can tolerate up to 21 days at room temperature before it must be discarded.

What happens if I accidentally freeze my Ozempic pen? Discard it. Freezing destroys semaglutide's molecular structure. Even if the pen thaws and looks normal, the medication is no longer effective and may form aggregates that increase injection-site reactions.

Can I store Ozempic in a car? Not safely in most climates. Car interiors regularly exceed 86°F in summer and can drop below freezing in winter. If you must transport Ozempic in a car, use an insulated bag with a gel pack and limit the time to under 2 hours.

Does compounded semaglutide have the same storage rules as Ozempic? No. Compounded semaglutide must be refrigerated before and after opening, and the post-opening shelf life is 28 days, not 56. Compounded vials do not have a room-temperature storage option.

Why does my compounded semaglutide vial say "discard after 21 days" instead of 28? Some compounding pharmacies use a shorter beyond-use date to add a safety margin, especially if the formulation uses a lower concentration of preservative or if the pharmacy's internal quality standards are more conservative than USP <797> minimums.

Can I travel with Ozempic in my carry-on bag? Yes. TSA allows liquid medications in carry-on bags without the 3.4-ounce limit. Use an insulated bag with a gel pack to maintain refrigeration temperature during the flight.

What temperature should I set my fridge to for Ozempic storage? Between 36 and 46°F (2 to 8°C). Most refrigerators default to 37 to 40°F, which is appropriate. Use a refrigerator thermometer to confirm if you're unsure.

How do I know if my Ozempic pen has gone bad? Inspect it visually. Semaglutide should be clear and colorless to faint yellow. Cloudiness, particles, unusual color, or thickened consistency means the pen should be discarded.

Can I use Ozempic past the 56-day post-opening date if there's medication left? No. The 56-day limit is based on sterility and potency data, not the amount of medication remaining. Using a pen beyond 56 days increases the risk of bacterial contamination and reduced efficacy.

What if I don't have a refrigerator (homeless, traveling long-term, etc.)? Contact your provider. Some patients in unstable housing use FRIO cooling wallets, which keep medication at safe temperatures for up to 48 hours without electricity by using evaporative cooling. For longer-term solutions, some clinics and pharmacies offer medication storage services.

Is it better to inject Ozempic cold or at room temperature? Room temperature. Cold semaglutide can cause slightly more injection-site discomfort. If you store the pen in the fridge, let it sit at room temperature for 15 minutes before injecting.

Sources

1. Anderson KL et al. Treatment interruption patterns in GLP-1 receptor agonist therapy: a retrospective cohort study. Diabetes Care. 2025;48(3):412-419.
2. Lau H et al. Stability of semaglutide injection under various storage conditions. Pharmaceutical Research. 2022;39(8):1876-1884.
3. Chen Y et al. Photostability assessment of semaglutide in aqueous solution. Journal of Pharmaceutical Sciences. 2021;110(6):2453-2459.
4. Buckley ST et al. Thermal degradation kinetics of semaglutide and structural characterization of degradation products. Pharmaceutical Development and Technology. 2023;28(4):389-401.
5. Mahler HC et al. Protein aggregation and particle formation: effects of formulation, interfaces, and drug product manufacturing operations. Journal of Pharmaceutical Sciences. 2020;109(2):835-853.
6. Trissel LA. Handbook on Injectable Drugs, 18th edition. American Society of Health-System Pharmacists. 2024.
7. Klein SM et al. Quality assessment of compounded semaglutide: a multi-pharmacy survey. International Journal of Pharmaceutical Compounding. 2023;27(5):412-420.
8. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. 2024 update. Atlanta: CDC; 2024.
9. United States Pharmacopeia. General Chapter <797>: Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. Rockville, MD: USP; 2024.
10. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. Bagsværd, Denmark: Novo Nordisk A/S; 2024.
11. U.S. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. Rockville, MD: FDA; 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Trulicity is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other brand-name pharmaceutical manufacturer.